1. What This Condition Is
Hepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV). Transmitted through blood-to-blood contact, the virus causes inflammation that, if untreated, progressively damages liver tissue over years or decades. Most people infected with hepatitis C have no acute symptoms and do not know they are infected. Over time, chronic hepatitis C can cause fibrosis, cirrhosis, liver failure, and hepatocellular carcinoma (liver cancer).
Hepatitis C is disproportionately prevalent among Vietnam-era and other veterans from the 1960s through the 1980s. During that period, military medical practices included the routine reuse of needles, jet air gun inoculation equipment, and surgical instruments that were not adequately sterilized between use. Blood transfusions performed before 1992 — when reliable screening for HCV became available — also represent a recognized exposure pathway. Tattooing in non-sterile settings during military service is another documented route.
The VA formally recognizes these service-related exposure routes. Veterans who received injections with shared equipment, jet air gun inoculations, blood transfusions before 1992, or received invasive medical or dental procedures during service, and who subsequently develop hepatitis C, can establish service connection through a direct nexus linking the in-service exposure to the diagnosis.
Hepatitis C is not an Agent Orange presumptive condition, but it is one of the most prevalent service-connected conditions in the Vietnam-era veteran population. Modern antiviral therapy (direct-acting antivirals, or DAAs) can now achieve sustained virologic response (SVR) — effectively curing the infection — in more than 95% of patients. However, a cure does not eliminate the VA disability rating for residual liver damage, and veterans who achieved SVR after years of infection may retain significant compensable hepatic residuals.
2. VA Rating Criteria
Hepatitis C is rated under 38 CFR § 4.114, Diagnostic Code 7354 (Hepatitis, infectious, including hepatitis C).
The rating is based on the severity of symptoms and the degree of liver damage:
| Rating | Criteria |
|---|---|
| 0% | Nonsymptomatic |
| 10% | Intermittent fatigue, malaise, and anorexia, or; incapacitating episodes (with prescribed bed rest and treatment by a physician) having a total duration of at least 1 week but less than 2 weeks during the past 12 months |
| 20% | Daily fatigue, malaise, and anorexia (without weight loss or hepatomegaly), or; incapacitating episodes having a total duration of at least 2 weeks but less than 4 weeks during the past 12 months |
| 40% | Daily fatigue, malaise, and anorexia, with minor weight loss and hepatomegaly, or; incapacitating episodes having a total duration of at least 4 weeks but less than 6 weeks during the past 12 months |
| 60% | Daily fatigue, malaise, and anorexia, with substantial weight loss (or other indication of malnutrition) and hepatomegaly, or; incapacitating episodes having a total duration of at least 6 weeks during the past 12 months |
| 100% | Near-total incapacitation |
Important note regarding SVR (cure): A veteran who achieves sustained virologic response through antiviral treatment no longer has active hepatitis C viral replication. However, if liver damage accumulated before treatment produced cirrhosis, portal hypertension, or hepatocellular carcinoma, those residuals are independently ratable under the applicable diagnostic codes for cirrhosis (DC 7312) or liver cancer (DC 7354 at 100% for active malignancy). The veteran's rating should reflect the residual damage, not merely the absence of active viral replication.
Cirrhosis: If hepatitis C has progressed to cirrhosis, the rating under DC 7312 (Cirrhosis) may produce a higher evaluation than DC 7354. The VA must use whichever code produces the higher rating.
3. What to Expect at Your C&P Exam
The examiner will review your hepatology or gastroenterology records, including liver enzyme values (ALT, AST), viral load history, liver biopsy or FibroScan results, and treatment history. If you achieved SVR, bring records documenting your pre-treatment liver damage and any post-treatment residuals.
Be prepared to describe your current symptoms with specificity: the frequency and severity of fatigue, whether it is intermittent or daily, whether it interferes with work and normal activities, whether you experience anorexia, weight loss, right upper quadrant pain, or jaundice. Describe any incapacitating episodes during the past twelve months: periods where you required physician-prescribed bed rest and treatment.
If you have progressed to cirrhosis, describe symptoms of portal hypertension: fluid accumulation (ascites), swollen legs, confusion from hepatic encephalopathy, and any episodes of gastrointestinal bleeding.
For the in-service exposure nexus, come prepared to describe specifically how you believe you were exposed during service: particular inoculation events, blood transfusions, surgical procedures, or other identified routes. A personal statement documenting the exposure history, combined with service medical records, is the foundation of the nexus case.
4. Evidence You Need to Win
Diagnosis: Current hepatology or gastroenterology records confirming hepatitis C infection or residual liver disease from prior HCV infection. Lab results showing liver function, viral load history, and imaging or biopsy documenting the degree of liver damage (fibrosis stage).
In-Service Exposure Evidence: This is the core of the service connection argument. Evidence of jet air gun inoculations (common at military induction and overseas processing centers), blood transfusions before 1992, surgical or dental procedures during service, or other documented blood-to-blood contact routes. Service medical records documenting inoculations, procedures, or transfusions are most persuasive. A personal statement describing the specific exposure circumstances is required when records are absent or incomplete.
Nexus Letter: A hepatologist, gastroenterologist, or infectious disease specialist must opine that the hepatitis C infection is at least as likely as not related to the identified in-service exposure. The letter must review the service records and exposure history, describe the current diagnosis, and provide the "at least as likely as not" nexus with medical rationale.
DBQ Form: VA Form 21-0960G-3 (Liver Conditions including Hepatitis). Your treating hepatologist or gastroenterologist should complete this form with current liver function values, fibrosis stage, symptom description, and nexus opinion.
Liver Damage Documentation: FibroScan results, liver biopsy reports, CT or MRI imaging of the liver, laboratory fibrosis indices (FIB-4, APRI), and documentation of any complications from cirrhosis or portal hypertension.
Personal Statement: Describe the in-service exposure in detail and describe how your hepatitis C and its residuals affect your daily function.
Buddy Statements (VA Form 21-10210): Fellow veterans who can corroborate the use of shared injection equipment or the circumstances of in-service medical procedures, or who can attest to your current functional limitations, can provide useful lay corroboration.
5. Secondary Conditions to Consider
Cirrhosis: Hepatitis C-related cirrhosis is the primary driver of severe liver disability. If cirrhosis is present, it is separately ratable under DC 7312 and may produce a higher rating than DC 7354 alone.
Hepatocellular Carcinoma: HCV cirrhosis significantly elevates the risk of liver cancer. If liver cancer develops secondary to service-connected hepatitis C, the malignancy is rated at 100% during active disease.
Depression and Anxiety: Hepatitis C and its treatment historically produced significant psychiatric effects. Depression is common in HCV patients both from the disease itself and from prior interferon-based therapy. Secondary mental health claims are ratable under 38 CFR 3.310.
Peripheral Neuropathy: HCV is associated with mixed cryoglobulinemia, which can cause peripheral neuropathy and joint pain. If neuropathy is documented and related to service-connected HCV, a secondary claim is viable.
Kidney Disease: Hepatitis C-related glomerulonephritis and cryoglobulinemic nephritis can cause kidney damage independent of general liver disease. Secondary renal claims may be appropriate.
Diabetes: HCV infection is associated with higher rates of insulin resistance and type 2 diabetes. Secondary diabetes from service-connected HCV may be ratable with a treating physician's nexus opinion.
6. Common Mistakes That Kill Claims
Not documenting the in-service exposure specifically. Hepatitis C is not a presumptive condition — the veteran must establish a nexus through a described in-service exposure. A general statement that "I was in the military" is not sufficient. Identify the specific inoculation events, procedures, or transfusions, and support them with service records or a detailed personal statement.
Accepting a 0% rating when symptoms persist after SVR. A viral cure does not mean the liver is undamaged. Veterans with residual fibrosis or cirrhosis continue to have ratable disability even after achieving SVR. The rating should reflect the residual hepatic damage.
Not pursuing cirrhosis as a separate condition. When HCV has caused cirrhosis, the veteran should be rated under both DC 7354 and DC 7312 (if the cirrhosis produces additional disability beyond what the hepatitis code captures) or under whichever code produces the higher rating.
Missing psychiatric secondary conditions. Hepatitis C is strongly associated with depression, both from the disease process and from the psychological burden of a chronic viral illness. A secondary mental health claim from service-connected HCV is medically and legally supportable.
Failing to obtain a hepatologist's nexus letter. Veterans often submit the diagnosis and service records but do not obtain a formal nexus letter. A physician opinion stating "at least as likely as not" with a rationale — specifically connecting the HCV diagnosis to the identified in-service exposure route — is required for service connection.
7. FWD Assist Resources
The following FWD Assist HQ books are directly relevant to a hepatitis C claim:
- Nexus Letters Guide — how to brief a hepatologist or infectious disease specialist to produce a nexus letter connecting HCV to an in-service exposure route
- C&P Exam Prep Guide — covers hepatic condition exams and how to document incapacitating episodes and functional limitations for the rating formula
- Secondary Conditions Guide — covers the HCV-to-cirrhosis, HCV-to-depression, and HCV-to-neuropathy secondary chains
- Agent Orange: The Complete Vietnam Veterans Claims Guide — relevant for Vietnam-era veterans whose medical procedure exposures occurred in the context of wartime service
All titles are available at fwdassisthq.com.
8. Get Help Without a Claim Shark
Free, accredited help is available through Veterans Service Organizations including the DAV, VFW, American Legion, and AMVETS. County Veterans Service Officers (CVSOs) file and manage claims at no cost.
Charging upfront fees to assist with a VA claim is illegal under 38 U.S.C. § 5905. VA-accredited attorneys and claims agents may charge fees only after an initial VA decision, capped at 20% of past-due benefits under 38 U.S.C. § 5904. No legitimate representative asks for money before your first decision.
Verify accreditation at va.gov/ogc/accreditation.asp.

